Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBioquell Regulatory News (BQE)

  • There is currently no data for BQE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

26 Sep 2013 07:00

RNS Number : 9236O
Bioquell PLC
26 September 2013
 



 

 

26 September, 2013

 

BIOQUELL PLC

Resignation of Mark Bodeker,Group Finance Director and Chief Operating Officer

 

Bioquell PLC ("Bioquell") (LSE symbol: BQE), provider of specialist bio-contamination control technologies to the international Healthcare, Life Sciences & Defence markets; and specialist testing services in the UK via its TRaC division, announces that Mark Bodeker, the Group's Finance Director and Chief Operating Officer, has decided that he will resign from Bioquell to pursue other interests. He will leave the Group in March 2014 at the end of his six months' notice period.

The Group has started to recruit a new Finance Director.

 

***************

 

Nigel Keen, Chairman of Bioquell PLC, said:

"Mark has been a key member of the senior team at Bioquell for the last 13 years."

"During his tenure Bioquell has grown from revenues of some £15 million in 2000 to £41 million in 2012."

"We wish Mark every success with his future career."

 

- Ends -

 

Enquiries:

 

Bioquell PLC 01264 835 900

Nigel Keen Chairman

Nick Adams Group Chief Executive

Mark Bodeker Chief Operating Officer / Finance Director

 

 

Notes to editors:

§ Bioquell is a UK-headquartered, international technology company with two divisions:

o Bio-decon (www.bioquell.com) which sells specialist bio-contamination control products and services into the Healthcare, Life Sciences and Defence sectors, with most of its revenues generated from overseas customers; and

o TRaC (www.tracglobal.com) which provides specialist Testing, Regulatory and Compliance services - including EMC, environmental and safety testing - principally to UK corporates.

§ Bioquell's bio-contamination control technology is principally based around hydrogen peroxide vapour ("HPV") - which is highly efficacious at eradicating micro-organisms such as bacteria and viruses at room temperature - and is subsequently broken down using specialist catalysts to water vapour and oxygen (hence an extremely 'green' technology) at the end of the bio-decontamination process.

§ For the last two years Bioquell has invested substantial sums in developing a new product range which has been designed to increase the proportion of recurring revenues from its HPV technology - and hence increase its quality of earnings; this range of new products was launched in the second half of 2012.

§ Bioquell's bio-contamination control technology:

o is used by bio-pharmaceutical, biotechnology and research institutions to provide sterile equipment and/or sterile working environments;

o is used to eradicate "superbugs" from hospitals; independent scientific research has demonstrated that 'bioquelling' hospital equipment and facilities reduces significantly the rates of hospital acquired infection;

o is used to provide single rooms to hospitals (via the ICE-pod) which currently only have open, multi-bed "Nightingale" ward structures

o has been incorporated in a wound-care product - BioxyQuell - which has received regulatory approval for use on chronic wounds in the European Union; and

§ Bioquell currently has overseas operations in the USA, France, Ireland, Singapore, China and Brazil.

TRaC sells its specialist services to the product development departments of a broad range of companies, principally based in the UK, with a particular focus on organisations operating in the aerospace and defence sectors.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALAMFTMBJTBIJ
Date   Source Headline
29th Jul 201610:27 amPRNForm 8.3 - Bioquell Plc
29th Jul 20169:24 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
28th Jul 201610:28 amPRNForm 8.3 - Bioquell Plc
28th Jul 20169:39 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
27th Jul 201610:25 amPRNForm 8.3 - Bioquell Plc
27th Jul 20169:33 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
26th Jul 20169:25 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
25th Jul 20169:07 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
22nd Jul 201612:55 pmPRNForm 8.3 - Bioquell plc
22nd Jul 20169:17 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
21st Jul 201611:36 amPRNForm 8.3 - Bioquell PLC
21st Jul 20169:40 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
20th Jul 201611:17 amPRNForm 8.3 - Bioquell PLC
20th Jul 20169:36 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
19th Jul 20169:31 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
18th Jul 20169:20 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
15th Jul 20169:11 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
13th Jul 20169:27 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
12th Jul 201610:00 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
11th Jul 20169:36 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
8th Jul 20168:54 amRNSForm 8.5 (EPT/RI)
7th Jul 20169:20 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
6th Jul 201610:03 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
5th Jul 20169:34 amRNSForm 8.5 (EPT/RI)
4th Jul 20163:09 pmRNSForm 8.3 - [Bioquell plc]
4th Jul 20162:08 pmRNSForm 8.3 - Bioquell Plc
4th Jul 20161:36 pmRNSForm 8.3 - Bioquell plc
4th Jul 20168:47 amRNSForm 8.5 (EPT/RI)
1st Jul 20169:52 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
30th Jun 201610:00 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
29th Jun 20166:14 pmRNSPDMR Dealing
29th Jun 20168:50 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
28th Jun 20168:56 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
27th Jun 201611:12 amRNSForm 8.3 - Bioquell
27th Jun 20168:52 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
24th Jun 201610:08 amRNSForm 8 (DD) - Bioquell PLC
24th Jun 20169:48 amRNSForm 8.3 - Bioquell Plc
24th Jun 20169:45 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
23rd Jun 201611:50 amRNSForm 8.3 - Bioquell Plc
23rd Jun 201611:30 amRNSForm 8.3 - Bioquell PLC
23rd Jun 201610:50 amRNSForm 8.5 (EPT/RI) - Bioquell Plc Amendment
23rd Jun 20168:56 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
22nd Jun 20163:13 pmRNSForm 8.3 - [Bioquell plc]
22nd Jun 20169:18 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
21st Jun 201610:41 amRNSForm 8.5 (EPT/RI)
21st Jun 20168:59 amRNSRule 2.10 Announcement
21st Jun 20168:00 amRNSDirectors' Dealings
21st Jun 20168:00 amRNSResult of Tender Offer
20th Jun 20163:08 pmRNSResults of General Meeting
20th Jun 20169:33 amRNSForm 8.5 (EPT/RI) - Bioquell Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.